BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10518305)

  • 1. Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives.
    Chen PJ; Chen DS
    Semin Liver Dis; 1999; 19(3):253-62. PubMed ID: 10518305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanism of hepatocarcinogenesis].
    Imazeki F; Saisho H
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.
    Dore MP; Realdi G; Mura D; Onida A; Massarelli G; Dettori G; Graham DY; Sepulveda AR
    Hum Pathol; 2001 Jul; 32(7):698-703. PubMed ID: 11486168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early molecular and genetic determinants of primary liver malignancy.
    Feitelson MA; Pan J; Lian Z
    Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic aspects of hepatocellular carcinogenesis.
    Ozturk M
    Semin Liver Dis; 1999; 19(3):235-42. PubMed ID: 10518303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
    Tharayil VS; Roberts LR
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and hepatitis B virus.
    Chan HL; Sung JJ
    Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
    Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
    Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
    Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
    J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New epidemiological data on liver oncogenesis.
    Kountouras J; Lygidakis NJ
    Hepatogastroenterology; 2000; 47(33):855-61. PubMed ID: 10919047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma.
    Huang HP; Tsuei DJ; Wang KJ; Chen YL; Ni YH; Jeng YM; Chen HL; Hsu HY; Chang MH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1206-14. PubMed ID: 16048568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.
    Nishikawa M; Nishiguchi S; Shiomi S; Tamori A; Koh N; Takeda T; Kubo S; Hirohashi K; Kinoshita H; Sato E; Inoue M
    Cancer Res; 2001 Mar; 61(5):1843-5. PubMed ID: 11280735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.